Literature DB >> 25103228

Statins and The BMJ.

Fiona Godlee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25103228     DOI: 10.1136/bmj.g5038

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort.

Authors:  Alan T Clarke; Paul C D Johnson; Gillian C Hall; Ian Ford; Peter R Mills
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

2.  Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.

Authors:  Paula Byrne; John Cullinan; Catríona Murphy; Susan M Smith
Journal:  BMJ Open       Date:  2018-02-08       Impact factor: 2.692

3.  Should all medical research be published? The moral responsibility of medical journal editors.

Authors:  Thomas Ploug
Journal:  J Med Ethics       Date:  2018-06-20       Impact factor: 2.903

Review 4.  Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews.

Authors:  Paula Byrne; John Cullinan; Amelia Smith; Susan M Smith
Journal:  BMJ Open       Date:  2019-04-23       Impact factor: 2.692

5.  Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).

Authors:  Shona J Livingstone; Helen C Looker; Tahira Akbar; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; John H Fuller; Helen M Colhoun
Journal:  Diabetologia       Date:  2015-11-17       Impact factor: 10.122

6.  The NHS Health Check in England: an evaluation of the first 4 years.

Authors:  John Robson; Isabel Dostal; Aziz Sheikh; Sandra Eldridge; Vichithranie Madurasinghe; Chris Griffiths; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ Open       Date:  2016-01-13       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.